The findings shed new light on human reproduction and suggest pathways for developing treatments to lower the risk of ...

Correspondence to Dr David S Lynch, Molecular Neuroscience, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK; david.lynch.13{at}ucl.ac.uk Inherited white matter disorders (IWMDs) comprise ...

Objective: This study evaluated the utility of single nucleotide polymorphism (SNP) microarray analysis in prenatal genetic assessment of fetuses diagnosed with congenital heart disease (CHD), ...

A new study hints at a "previously recognized" mechanism that links a rare chromosomal disorder to schizophrenia. When you purchase through links on our site, we may earn an affiliate commission. Here ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

Rare disease genetic testing holds significant promise for advancing healthcare. The global market for rare disease genetic testing has expanded substantially due to rising demand for early detection ...

Objectives Current evidence recommend Microarray testing as first-tier investigation for Children with developmental Delay and moderate to severe intellectual disability. Our aim is to see the ...